121 related articles for article (PubMed ID: 30106441)
1. Farnesoid X receptor inhibits proliferation of human colorectal cancer cells via the miR‑135A1/CCNG2 signaling pathway.
Qiao P; Li S; Zhang H; Yao L; Wang F
Oncol Rep; 2018 Oct; 40(4):2067-2078. PubMed ID: 30106441
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-1246 promotes growth and metastasis of colorectal cancer cells involving CCNG2 reduction.
Wang S; Zeng Y; Zhou JM; Nie SL; Peng Q; Gong J; Huo JR
Mol Med Rep; 2016 Jan; 13(1):273-80. PubMed ID: 26573378
[TBL] [Abstract][Full Text] [Related]
3. CCNG2 suppressor biological effects on thyroid cancer cell through promotion of CDK2 degradation.
Li WJ; Liu GL; Yu F; Xiang XX; Lu YF; Xiao HZ; Shi YP
Asian Pac J Cancer Prev; 2013; 14(10):6165-71. PubMed ID: 24289643
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-93 regulates cyclin G2 expression and plays an oncogenic role in laryngeal squamous cell carcinoma.
Xiao X; Zhou L; Cao P; Gong H; Zhang Y
Int J Oncol; 2015 Jan; 46(1):161-74. PubMed ID: 25309979
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of metadherin inhibits cell proliferation and migration in colorectal cancer.
Li JW; Huang CZ; Li JH; Yuan JH; Chen QH; Zhang WF; Xu ZS; Liu YP; Li Y; Zhan MX; Lu LG
Oncol Rep; 2018 Oct; 40(4):2215-2223. PubMed ID: 30015962
[TBL] [Abstract][Full Text] [Related]
6. miR‑873 inhibits colorectal cancer cell proliferation by targeting TRAF5 and TAB1.
Gong H; Fang L; Li Y; Du J; Zhou B; Wang X; Zhou H; Gao L; Wang K; Zhang J
Oncol Rep; 2018 Mar; 39(3):1090-1098. PubMed ID: 29328486
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of REG3A in colorectal cancer cells confers proliferation and correlates with colorectal cancer risk.
Ye Y; Xiao L; Wang SJ; Yue W; Yin QS; Sun MY; Xia W; Shao ZY; Zhang H
Oncotarget; 2016 Jan; 7(4):3921-33. PubMed ID: 26646797
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of microRNA-23b-3p induced by farnesoid X receptor regulates the proliferation and apoptosis of osteosarcoma cells.
Wu B; Xing C; Tao J
J Orthop Surg Res; 2019 Nov; 14(1):398. PubMed ID: 31779647
[TBL] [Abstract][Full Text] [Related]
9. CCNG2 expression is downregulated in colorectal carcinoma and its clinical significance.
Sun GG; Zhang J; Hu WN
Tumour Biol; 2014 Apr; 35(4):3339-46. PubMed ID: 24307622
[TBL] [Abstract][Full Text] [Related]
10. MiR-489 suppresses tumor growth and invasion by targeting HDAC7 in colorectal cancer.
Gao S; Liu H; Hou S; Wu L; Yang Z; Shen J; Zhou L; Zheng SS; Jiang B
Clin Transl Oncol; 2018 Jun; 20(6):703-712. PubMed ID: 29071516
[TBL] [Abstract][Full Text] [Related]
11. Decreased Expression of MIR-134 and its Clinical Significance in Human Colorectal Cancer.
Xie Y; Song J; Zong Q; Wang A; Yang Y; Liu F; Meng X
Hepatogastroenterology; 2015 May; 62(139):615-9. PubMed ID: 26897940
[TBL] [Abstract][Full Text] [Related]
12. MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer.
Christensen LL; Tobiasen H; Holm A; Schepeler T; Ostenfeld MS; Thorsen K; Rasmussen MH; Birkenkamp-Demtroeder K; Sieber OM; Gibbs P; Lubinski J; Lamy P; ; Laurberg S; Oster B; Hansen KQ; Hagemann-Madsen R; Byskov K; Ørntoft TF; Andersen CL
Int J Cancer; 2013 Jul; 133(1):67-78. PubMed ID: 23280316
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer.
Toiyama Y; Yasuda H; Saigusa S; Tanaka K; Inoue Y; Goel A; Kusunoki M
Carcinogenesis; 2013 Nov; 34(11):2548-57. PubMed ID: 24001454
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Transcription Termination Factor 1 is Associated with a Poor Prognosis in Patients with Colorectal Cancer.
Ueda M; Iguchi T; Nambara S; Saito T; Komatsu H; Sakimura S; Hirata H; Uchi R; Takano Y; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1490-8. PubMed ID: 26036188
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-340 promotes the tumor growth of human gastric cancer by inhibiting cyclin G2.
Yin G; Zhou H; Xue Y; Yao B; Zhao W
Oncol Rep; 2016 Aug; 36(2):1111-8. PubMed ID: 27374211
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-217 functions as a prognosis predictor and inhibits colorectal cancer cell proliferation and invasion via an AEG-1 dependent mechanism.
Wang B; Shen ZL; Jiang KW; Zhao G; Wang CY; Yan YC; Yang Y; Zhang JZ; Shen C; Gao ZD; Ye YJ; Wang S
BMC Cancer; 2015 May; 15():437. PubMed ID: 26016795
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of NEK2 by microRNA-128 methylation is associated with poor prognosis in colorectal cancer.
Takahashi Y; Iwaya T; Sawada G; Kurashige J; Matsumura T; Uchi R; Ueo H; Takano Y; Eguchi H; Sudo T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
Ann Surg Oncol; 2014 Jan; 21(1):205-12. PubMed ID: 24046120
[TBL] [Abstract][Full Text] [Related]
18. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X
Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539
[TBL] [Abstract][Full Text] [Related]
19. High expression of fibronectin is associated with poor prognosis, cell proliferation and malignancy via the NF-κB/p53-apoptosis signaling pathway in colorectal cancer.
Yi W; Xiao E; Ding R; Luo P; Yang Y
Oncol Rep; 2016 Dec; 36(6):3145-3153. PubMed ID: 27748871
[TBL] [Abstract][Full Text] [Related]
20. Role of SMC1A overexpression as a predictor of poor prognosis in late stage colorectal cancer.
Wang J; Yu S; Cui L; Wang W; Li J; Wang K; Lao X
BMC Cancer; 2015 Mar; 15():90. PubMed ID: 25884313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
